The effect of continuous positive airway pressure therapy on arterial stiffness and endothelial function in obstructive sleep apnea: A randomized controlled trial in patients without cardiovascular disease

Sleep Medicine

Volumn 14, Issue 12, 2013, Pages 1260-1265

  Jones, Anne ^a   Vennelle, Marjorie ^a   Connell, Martin ^a   McKillop, Graham ^a   Newby, David E ^b   Douglas, Neil J ^a   Riha, Renata L ^a  

^a ROYAL INFIRMARY OF EDINBURGH   (United Kingdom)

^b UNIVERSITY OF EDINBURGH   (United Kingdom)

Author keywords

Aortic distensibility; Arterial stiffness; Augmentation index; Cardiovascular disease; Continuous positive airway pressure (CPAP) therapy; Endothelial function; Obstructive sleep apnea (OSA); Pulse wave velocity

Indexed keywords

GLYCERYL TRINITRATE; SALBUTAMOL;

ADULT; AORTA ELASTICITY; APNEA HYPOPNEA INDEX; APPLANATION TONOMETER; ARTERIAL STIFFNESS; ARTERY COMPLIANCE; ARTICLE; AUGMENTATION INDEX; BLOOD VESSEL REACTIVITY; CARDIOVASCULAR FUNCTION; CARDIOVASCULAR MAGNETIC RESONANCE; CLINICAL ARTICLE; CONTROLLED STUDY; CROSSOVER PROCEDURE; DOUBLE BLIND PROCEDURE; ENDOTHELIUM; EXCESSIVE DAYTIME SOMNOLENCE; FEMALE; HUMAN; MALE; MORBIDITY; MORTALITY; POSITIVE END EXPIRATORY PRESSURE; PRIORITY JOURNAL; PULSE WAVE; RANDOMIZED CONTROLLED TRIAL; SLEEP DISORDERED BREATHING; SOMNOLENCE; SYSTOLIC BLOOD PRESSURE;

AORTIC DISTENSIBILITY; ARTERIAL STIFFNESS; AUGMENTATION INDEX; CARDIOVASCULAR DISEASE; CONTINUOUS POSITIVE AIRWAY PRESSURE (CPAP) THERAPY; ENDOTHELIAL FUNCTION; OBSTRUCTIVE SLEEP APNEA (OSA); PULSE WAVE VELOCITY;

ADRENERGIC BETA-2 RECEPTOR AGONISTS; ADULT; ALBUTEROL; AORTA; BLOOD FLOW VELOCITY; CARDIOVASCULAR DISEASES; CONTINUOUS POSITIVE AIRWAY PRESSURE; CROSS-OVER STUDIES; DISORDERS OF EXCESSIVE SOMNOLENCE; ENDOTHELIUM, VASCULAR; FEMALE; HUMANS; MALE; MIDDLE AGED; NITROGLYCERIN; PLACEBO EFFECT; POLYSOMNOGRAPHY; PULSATILE FLOW; SLEEP APNEA, OBSTRUCTIVE; TREATMENT OUTCOME; VASCULAR STIFFNESS; VASODILATOR AGENTS;

EID: 84888128406     PISSN: 13899457     EISSN: 18785506     Source Type: Journal    
DOI: 10.1016/j.sleep.2013.08.786     Document Type: Article

References (38)

1. Young T., Palta M., Dempsey J., Skatrud J., Weber S., Badr S. The occurrence of sleep-disordered breathing among middle-aged adults. N Engl J Med 1993, 328:1230-1235.
2. Marin J.M., Carrizo S.J., Vicente E., Agusti A.G. Long-term cardiovascular outcomes in men with obstructive sleep apnoea-hypopnoea with or without treatment with continuous positive airway pressure: an observational study. Lancet 2005, 365:1046-1053.
3. Shahar E., Whitney C.W., Redline S., Lee E.T., Newman A.B., Nieto F.J., et al. Sleep-disordered breathing and cardiovascular disease: cross-sectional results of the Sleep Heart Health Study. Am J Respir Crit Care Med 2001, 163:19-25.
4. Stradling J.R., Pepperell J.C., Davies R.J. Sleep apnoea and hypertension: proof at last?. Thorax 2001, 56(Suppl. 2):ii45-49.
5. Davies R.J., Belt P.J., Roberts S.J., Ali N.J., Stradling J.R. Arterial blood pressure responses to graded transient arousal from sleep in normal humans. J Appl Physiol 1993, 74:1123-1130.
6. Jelic S., Bartels M.N., Mateika J.H., Ngai P., DeMeersman R.E., Basner R.C. Arterial stiffness increases during obstructive sleep apneas. Sleep 2002, 25:850-855.
7. Hedner J., Ejnell H., Sellgren J., Hedner T., Wallin G. Is high and fluctuating muscle nerve sympathetic activity in the sleep apnoea syndrome of pathogenetic importance for the development of hypertension?. J Hypertens Suppl 1988, 6:S529-31.
8. Ryan S., Taylor C.T., McNicholas W.T. Systemic inflammation: a key factor in the pathogenesis of cardiovascular complications in obstructive sleep apnoea syndrome?. Postgrad Med J 2009, 85:693-698.
9. Jones A., Vennelle M., Connell M., McKillop G., Newby D.E., Douglas N.J., et al. Arterial stiffness and endothelial function in obstructive sleep apnoea/hypopnoea syndrome. Sleep Med 2013, 14:428-432.
10. Campos-Rodriguez F., Martinez-Garcia M.A., de la Cruz-Moron I., Almeida-Gonzalez C., Catalan-Serra P., Montserrat J.M. Cardiovascular mortality in women with obstructive sleep apnea with or without continuous positive airway pressure treatment: a cohort study. Ann Intern Med 2012, 156:115-122.
11. Marin J.M., Agusti A., Villar I., Forner M., Nieto D., Carrizo S.J., et al. Association between treated and untreated obstructive sleep apnea and risk of hypertension. JAMA 2012, 307:2169-2176.
12. Faccenda J.F., Mackay T.W., Boon N.A., Douglas N.J. Randomized placebo-controlled trial of continuous positive airway pressure on blood pressure in the sleep apnea-hypopnea syndrome. Am J Respir Crit Care Med 2001, 163:344-348.
13. Pepperell J.C., Ramdassingh-Dow S., Crosthwaite N., Mullins R., Jenkinson C., Stradling J.R., et al. Ambulatory blood pressure after therapeutic and subtherapeutic nasal continuous positive airway pressure for obstructive sleep apnoea: a randomised parallel trial. Lancet 2002, 359:204-210.
14. Ip M.S., Tse H.F., Lam B., Tsang K.W., Lam W.K. Endothelial function in obstructive sleep apnea and response to treatment. Am J Respir Crit Care Med 2004, 169:348-353.
15. Cross M.D., Mills N.L., Al-Abri M., Riha R., Vennelle M., Mackay T.W., et al. Continuous positive airway pressure improves vascular function in obstructive sleep apnoea/hypopnoea syndrome: a randomised controlled trial. Thorax 2008, 63:578-583.
16. Rechtschaffen A., Kales A. A manual of standardized terminology, techniques and scoring system for sleep stages of human subjects 1968, BIS/BRI, UCLA, Los Angeles (CA).
17. Iber C., Ancoli-Israel S., Chessan A.L., Quan S.F. The American academy of sleep medicine manual for the scoring of sleep and associated events: rules, terminology and technical specifications 2007, AASM, Westchester (IL). 1st ed.
18. Laurent S., Cockcroft J., Van Bortel L., Boutouyrie P., Giannattasio C., Hayoz D., et al. Expert consensus document on arterial stiffness: methodological issues and clinical applications. Eur Heart J 2006, 27:2588-2605.
19. Wilkinson I.B., Hall I.R., MacCallum H., Mackenzie I.S., McEniery C.M., van der Arend B.J., et al. Pulse-wave analysis: clinical evaluation of a noninvasive, widely applicable method for assessing endothelial function. Arterioscler Thromb Vasc Biol 2002, 22:147-152.
20. AtCor Medical. Instructions for PWV measurements. [Accessed September 23, 2013]. http://atcormedical.com.
21. Bazzano L.A., Khan Z., Reynolds K., He J. Effect of nocturnal nasal continuous positive airway pressure on blood pressure in obstructive sleep apnea. Hypertension 2007, 50:417-423.
22. Vlachopoulos C., Aznaouridis K., O'Rourke M.F., Safar M.E., Baou K., Stefanadis C. Prediction of cardiovascular events and all-cause mortality with central haemodynamics: a systematic review and meta-analysis. Eur Heart J 2010, 31:1865-1871.
23. Kohler M., Pepperell J.C., Casadei B., Craig S., Crosthwaite N., Stradling J.R., et al. CPAP and measures of cardiovascular risk in males with OSAS. Eur Respir J 2008, 32:1488-1496.
24. Buchner N.J., Quack I., Stegbauer J., Woznowski M., Kaufmann A., Rump L.C. Treatment of obstructive sleep apnea reduces arterial stiffness. Sleep Breath 2012, 16:123-133.
25. Willum-Hansen T., Staessen J.A., Torp-Pedersen C., Rasmussen S., Thijs L., Ibsen H., et al. Prognostic value of aortic pulse wave velocity as index of arterial stiffness in the general population. Circulation 2006, 113:664-670.
26. Drager L.F., Bortolotto L.A., Figueiredo A.C., Krieger E.M., Lorenzi G.F. Effects of continuous positive airway pressure on early signs of atherosclerosis in obstructive sleep apnea. Am J Respir Crit Care Med 2007, 176:706-712.
27. Doonan R.J., Scheffler P., Lalli M., Kimoff R.J., Petridou E.T., Daskalopoulos M.E., et al. Increased arterial stiffness in obstructive sleep apnea: a systematic review. Hypertens Res 2011, 34:23-32.
28. Keles T., Durmaz T., Bayram N.A., Ciftci B., Yeter E., Akcay M., et al. Effect of continuous positive airway pressure therapy on aortic stiffness in patients with obstructive sleep apnea syndrome. Echocardiography 2009, 26:1217-1224.
29. Kylintireas I., Craig S., Nethononda R., Kohler M., Francis J., Choudhury R., et al. Atherosclerosis and arterial stiffness in obstructive sleep apnea - a cardiovascular magnetic resonance study. Atherosclerosis 2012, 222:483-489.
30. Imadojemu V.A., Gleeson K., Quraishi S.A., Kunselman A.R., Sinoway L.I., Leuenberger U.A. Impaired vasodilator responses in obstructive sleep apnea are improved with continuous positive airway pressure therapy. Am J Respir Crit Care Med 2002, 165:950-953.
31. Lattimore J.L., Wilcox I., Skilton M., Langenfeld M., Celermajer D.S. Treatment of obstructive sleep apnoea leads to improved microvascular endothelial function in the systemic circulation. Thorax 2006, 61:491-495.
32. Bayram N.A., Ciftci B., Keles T., Durmaz T., Turhan S., Bozkurt E., et al. Endothelial function in normotensive men with obstructive sleep apnea before and 6 months after CPAP treatment. Sleep 2009, 32:1257-1263.
33. Robinson G.V., Smith D.M., Langford B.A., Davies R.J., Stradling J.R. Continuous positive airway pressure does not reduce blood pressure in nonsleepy hypertensive OSA patients. Eur Respir J 2006, 27:1229-1235.
34. Barbé F., Durán-Cantolla J., Sánchez-de-la-Torre M., Martínez-Alonso M., Carmona C., Barceló A., et al. Effect of continuous positive airway pressure on the incidence of hypertension and cardiovascular events in nonsleepy patients with obstructive sleep apnea: a randomized controlled trial. JAMA 2012, 307:2161-2168.
35. Garvey J.F., Taylor C.T., McNicholas W.T. Cardiovascular disease in obstructive sleep apnoea syndrome: the role of intermittent hypoxia and inflammation. Eur Respir J 2009, 33:1195-1205.
36. Engleman H.M., Martin S.E., Deary I.J., Douglas N.J. Effect of continuous positive airway pressure treatment on daytime function in sleep apnoea/hypopnoea syndrome. Lancet 1994, 343:572-575.
37. Brown D.L., Anderson C.S., Chervin R.D., Kushida C.A., Lewin D.S., Malow B.A., et al. Ethical issues in the conduct of clinical trials in obstructive sleep apnea. J Clin Sleep Med 2011, 7:103-108.
38. Honda T., Hamada M., Shigematsu Y., Matsumoto Y., Matsuoka H., Hiwada K. Effect of antihypertensive therapy on aortic distensibility in patients with essential hypertension: comparison with trichlormethiazide, nicardipine and alacepril. Cardiovasc Drugs Ther 1999, 13:339-346.